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Abstract
The illumination system composed of LEDs is an anatomically adjustable 
device of high intensity that can be applied in different areas of the body. It can 
be applied in health care, as in the dermatological and esthetic treatments. The 
device improved the treatment of pathological diseases (e.g. actinic keratosis) since 
disseminated lesions were reached in a single application, thus reducing the time of 
the procedure and ensuring homogeneous light distribution. It was compared with 
a smaller and non-adjustable illumination device and evaluated in the treatment of 
actinic keratosis. The results showed its versatile application and a uniform adjust-
ment to body curvatures.
Keywords: light-emitting diodes, anatomical LED system, photodynamic therapy, 
actinic keratosis
1. Introduction
Topical photodynamic therapy (PDT) using 5-aminolevulinic acid (ALA) and its 
variants as the methyl-aminolevulinate (MAL) is a well-established technique that 
requires a light source appropriate to a specific application, such as cancer types and 
precancerous lesions [1, 2]. ALA and its variants are the main precursors of proto-
porphyrin IX (PpIX), which is an endogenous photosensitizer (PS) and it is part of 
the heme biosynthesis pathway. PpIX selectively sensitizes the diseased cells, and 
when it is excited by light of a certain wavelength, interact with molecular oxygen 
producing reactive cytotoxic species, causing cells death by necrosis, apoptosis or 
autophagy. However, for PDT to work is required, a PS, the wavelength to excite the 
PS, and the molecular oxygen present in the tissue [3].
Lasers and light-emitting diodes (LEDs) are suitable light sources for PDT appli-
cations. But fiber-optic-lasers are more appropriate for light endoscopes device, or 
even for intraoperative cavities illumination. In general, illumination devices have 
light emitters of fixed geometry. An exception is the recently developed fabric-like 
material made with single-mode optical fibers adjustable to a specific application or 
anatomic site [4–6].
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Several authors have reported PDT applications in dermatology for not only 
non-melanoma skin cancer but esthetic treatments [7–10]. Therefore, laser devices 
with optical fibers are not convenient, since large areas and anatomic sites must be 
considered.
On the other hand, Light Emitting Diodes (LEDs) are an alternative illumina-
tion system and can deliver the necessary intensities for PDT performance at lower 
costs. LED devices have already been used in PDT for the treatment of skin cancer 
and esthetic procedures [11–16], however, its field of illumination is limited and it is 
not anatomically adjustable to the body, which hampers the treatment of areas not 
reached by the light. Moreover, it is not effective for the treatment of large lesions 
located in the head, neck, legs, and arms, due to its non-conformability, which 
causes the illumination not to be homogenous. An example is the treatment of 
actinic keratosis (AK), which are lesions more likely to occur on the face and scalp 
due to high exposure to the sun [6–10].
The treatment of AK with photodynamic therapy requires illumination of the 
entire region at the same intensity. In this case, the anatomical device enables the 
use of the PDT procedure and optimizes the application time.
The topical application of the ALA prodrug and its derivatives in PDT can be 
used by several light sources, so long as the photosensitive agents are activated by 
the wavelengths. Because the PpIX accumulated by the application of the prodrug 
has absorption peaks in the Soret band and four minor peaks in the Q band, 510 nm, 
545 nm, 580 nm, and 630 nm. Thus, blue light-emitting at 450 nm and red light-
emitting at 630 nm from LED devices can be applied for the activation of PpIX. 
However, blue light penetrates superficial layers of the skin and red-light deeper 
layers of the skin [17–20].
Our main concern was to produce a flexible LED illumination system of high-
power that operates at 450 ± 10 nm and 630 ± 10 nm wavelengths; therefore, the 
device was tested by engineers and in clinical applications (AKs treatment and 
esthetic dysfunctions) [20, 21].
2. Illumination systems: small, fixed and adjustable array
Figure 1a shows LINCE® (MMOptics, São Carlos, SP, Brazil) device, it is treat-
ment system and comprised of a circular probe (on the left) with approximately 
9.0 cm2 area that emits at 630 nm ± 10; on the right, it is a diagnostic system, which 
emits at 405 ± 10 nm and collects the image of the protoporphyrin IX formation 
induced by a topical application of a precursor on the skin. Figure 1b displays 
a square illumination of LINCE® accessory in a 61 cm2 area, with LEDs (light-
emitting diodes) emitting at 630 ± 10 nm.
The system is recommended for small lesions, such as superficial or nodular 
Basal Cell Carcinoma (BCC). It was developed in the Brazilian Skin Cancer PDT 
program, currently, already it is used in the clinics. [1, 4, 13–15].
The device was designed for improving the large area attachment of LINCE® 
accessory and providing an extra accessory that can multiply the possibilities of the 
Clinical PDT treatment. It was developed in cooperation with MMOptics industry 
(São Carlos, SP, Brazil) and Technological Support Laboratory (São Carlos Institute 
of Physics, University of São Paulo, São Carlos, SP, Brazil) and assembled by rectan-
gular modules (up to 10, in principle).
However, a version with 5 modules composing a 192 cm2 area of illumination 
(Figure 2a) was employed in this study. It consists of five LEDs (Luxeon Rebel, 
Lumileds Company) boards, thus totaling 30 LEDs emitting at 630 ± 10 nm, and 25 
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LEDs emitting at 450 ± 10 nm. A flexible tube was added for adapting the equip-
ment to regions of the body (Figure 2b), and a handle facilitated its use in areas 
of curvature (Figure 2c) and avoided the bending of the plates with LEDs. Power 
sources of 16 V for emission at 450 ± 10 nm, and 5 V for emission at 630 ± 10 nm, 
both with 3 A electric current, are connected to the device. Below is the description 
of the power buttons (Figure 2d):
1. On/off button for the selection of the wavelength (450 nm or 630 nm).
2. Timer button for the selection of the illumination time in minutes.
3. Start/Stop button.
Figure 1. 
(a) LINCE® equipment (MMOptics – Brazil): left - treatment system emitting at 630 nm; right - diagnostic 
system emitting at 405 ± 10 nm. (b) Square illumination of the LINCE® accessory emitting at 630 ± 10 nm.
Figure 2. 
Anatomically adjustable device. (a) Front of the equipment, where the LEDs are coupled and protected by 
plastic covers. (b) Side of the device, with an acrylic tube that facilitates its handling. (c) Adaptation of its 
curvature to the body by the acrylic tube. (d) Electronic box with the sequence of the drive buttons.
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Figure 4. 
Images of a treatment performed on the face. Devices emit at 630 nm. (a) LINCE® (MMOptics, São Carlos, 
SP, Brazil) - illumination system for treatment. (b) LINCE® accessory.
4. Button that turns on the equipment according to the wavelength selected (1).
5. Button that disables the equipment if pressed for a few seconds.
Figure 3 shows the way the equipment can be used in different parts of the body, 
according to an adequate anatomic configuration.
Figure 4 shows LINCE® (MMOptics, São Carlos, SP, Brazil) lighting system and 
its accessory (the 61 cm2 fixed array) for the treatment of large areas. LINCE® is 
not adequate for treatments that require illumination of a larger area, since it does 
not have good applicability - it must be pushed away, which reduces the intensity 
and increases the application time. LINCE® accessory (the 61 cm2 fixed array) has 
a larger area; however, it is fixed and does not fit the body anatomy. The delivered 
dose decreases when it moved away from the patient’s skin, and a longer time is 
Figure 3. 
Possible configurations of the device for different regions of the body. (a) Neck; (b) shin; (c) back;  
(d) quadriceps and (e) head.
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necessary for the achievement of the desired effect. In addition, the irradiance 
delivered on the target tissue is not homogeneous.
Figure 5 shows the PDT treatment for AK and acne vulgaris by the anatomi-
cal device.
AKs lesions often appear scattered in a specific region of the body most 
exposed to the sun. The device optimizes the PDT treatment so that it covers 
extensive regions and delivers the necessary intensity. Figure 5a shows the device 
used for the treatment of AKs at the back of the hand. The device enabled the 
treatment of both hands concomitantly. Figure 5b displays the device being 
used in patients with actinic keratosis on top of the head. The shape of the device 
adjusted to the anatomy of the region promotes uniform illumination and covers 
the entire area of lesions, thus reducing the number of exposures needed to treat 
larger areas effectively.
Figure 5c and d show the device being used for the treatment of acne vulgaris 
in the face. It was leaned against the treated area so that the desired intensity and 
fluency rate could be delivered. The equipment was moved a little away from the 
patient to allow a clearer photograph and the area treated. A flat device would not 
treat the surface so closely and uniformly.
2.1 Optical characteristics - adjustable array
The light distribution was measured using the laser power meter (LabMax-TOP, 
Coherent Inc., Santa Clara, USA). It has a 0.5 cm2 circular area sensor and the 
wavelength was configured for the collection of the intensity measured. The light 
distribution was measured 5 cm away from the equipment, and the power meter 
Figure 5. 
(a) AK treatment with the anatomical device at the back of the hand. Both hands can be treated 
concomitantly. (b) AK treatment with the anatomical device in the head region, covering its whole region.  
(c) and (d) PDT procedure for acne vulgaris on the face.
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sensor was scanned throughout the device area. The distance from each point col-
lected was the diameter of the power meter detector.
Figure 6 shows the measurement of intensity (collected point to point) of the 
light emission of the anatomical device.
The device remained on for 20 minutes to perform the warm-up test, and it did 
not heat up, which has proven the light-emitting surface causes no thermal damage 
to the skin.
Planar irradiance distribution was mapped out at a range of distances from the 
light source. Measurements were collected from the distance zero until 5 cm of the 
laser power meter, varying each 1 cm (Figure 7). The covered area of the measure-
ments corresponds to 192 cm2 (13 × 15 cm). The intensity fluctuates with a small decay 
at the boundary for both wavelengths. We calculated the average intensity, consider-
ing a continuous emitting surface (Figure 8). The intensity at any z-axis from the 
emitting surface can be evaluated through the integration of all elementary emitters.
To calculate the intensity at a certain position (x, y, z) above the surface, we can 
proceed with the sum of the contributions of all the emitters distributed on the 
surface. Imagine that in each position determined by the coordinates (x’, y’) there 
is an emitting element. The contribution of all of them to the intensity at the point 
Figure 6. 
Intensity measurements were collected from point to point in the anatomical device area. (a) Intensity emitting 
at 630 ± 10 nm and (b) intensity emitting at 450 ± 10 nm.
7Anatomically Adjustable Device for Large-Area Photodynamic Therapy
DOI: http://dx.doi.org/10.5772/intechopen.93917
outside the surface (x, y, z) is then given by the integral of all elements, covering 
the entire area that contains emitters. Considering as in Figure 8, where we repre-
sent in a simplified way the position of the issuer and the point considered, we have 
the integral:
 ( )
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¢ ¢
- ¢
=
- + +
∬  (1)
Figure 7. 
Intensity versus distance. The intensity was measured by LabMax-TOP laser power meter (Coherent Inc., 
Santa Clara, USA). Measurements were collected every 1 cm from the device up to 5 cm and scanned 
throughout the device area.
Figure 8. 
Average intensity calculated by the integral of the elementary emitters at any point of the intensity (x′,y′).
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If we consider a special point of interest, the central point of the distribution 
(x = 0 and y = 0), we have that the previous integral is reduced to:
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 If 0I  is close to the emitters intensity (z → 0), the intensity at point (x, y, z) is 
given by 
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At the center of the illuminating area (x = y = 0), at any distance z
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The integral can be solved by traditional approximation and results in a center 
average intensity of
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The calibration of 0I  at certain z provides a center intensity at a distance z from 
the device shown in Figure 9.
Figure 9. 
Intensity decay caused by an increase in the distance from the device to the target tissue.
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The ideal distance for the treatment is up to 1 cm because since the presence 
of the emitter is dominant in this distance, the intensity fluctuates. Therefore, if 
the expected average is considered the center intensity, the dose can be obtained 
from Figure 9, and for each 1 s illumination, the intensity (mW/cm2) corresponds 
to the 10−3 J/cm2 total dose delivered. At a 1 cm distance, the total dose delivery is 
1.32 J/cm2 energy, while at 5 cm distance, it decays to 0.39 J/cm2.
Generally, the total dose applied in the PDT procedures ranges from 30 to 
100 J/cm2, so that for device equates a 22 to 66-minute application time, respec-
tively. This time increases if the illumination distance increases. Those times are 
equivalent to 450 ± 10 nm and 630 ± 10 nm emissions.
3. Clinical demonstration: anatomical device (adjustable array)
LINCE® accessory (fixed array) and the anatomical device (adjustable array) 
were designed towards meeting the clinical needs for the PDT application in the 
AK treatment. However, esthetics and rehabilitation procedures that use low-
power laser have been intensively studied, and more versatile devices with larger 
illumination areas have attracted more health professionals. The development of a 
device that enables the choice of wavelength is fundamental for the adoption of the 
appropriate procedure for a given treatment.
Two patients with a clinical diagnosis of AK were recruited to be treated with 
PDT using the anatomical device (Figure 10). The protocol applied was ALA-20% 
cream; incubation time 1 h 30 min; total dose 50 J/cm2, emission at 630 ± 10 nm. 
After one month, no residual lesion was observed in the nose; the scalp region 
showed a residual lesion, which indicates an 85% elimination.
The anatomical device (adjustable array) was able to cover all extension of the 
lesions treated on the nose and scalp. The emission surface was leaning against 
the treatment region and there was no heating, which enabled the delivery of the 
adequate intensity.
LINCE® accessory (the 61 cm2 fixed array) was observed that excessive heat-
ing occurred when applied in contact with the treatment area, causing greater 
Figure 10. 
(a) AK lesion on the nose. (b) 30 days after the PDT procedure - no residual lesion. (c) Approximately six AKs 
lesions scattered on the scalp region. (d) 30 days after the PDT procedure - a residual lesion.
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discomfort to the patient. This is due to its geometry of heat dissipation because it 
has more LEDs per area than the anatomical device (192 cm2 adjustable array). In the 
anatomical device, the LEDs are divided between the boards, thus obtaining a better 
air circulation mechanism and more heat dissipation. Therefore, the anatomical 
device is more comfortable for the patient and it is possible to apply it in contact with 
the treated area and operating at high intensity without causing excessive heating.
4. Conclusion
LINCE® (MMOptics, São Carlos, SP, Brazil) device has become excellent com-
mercial equipment for the PDT treatment for non-melanoma skin cancer in Brazil. 
Thereby, the development of an anatomical device with a larger illumination area 
becomes more efficient to treat extensive lesions.
The anatomical device was designed to optimize the PDT procedure in AK 
lesions scattered in a specific region of the body and in body sites, where a machine 
is required for the obtaining of the curvature according to the anatomy of the 
treated region. The device treated extensive lesions and reached their entire 
extension. It suffered no heating during treatments, therefore the thermal energy 
dissipation in this shape was more effective, and caused no sensation of thermal 
discomfort to the patient.
The anatomical device can be used for several dermatological clinical applica-
tions, including esthetic procedures for facial, body, and capillary treatments.
Further clinical tests will be conducted and, if necessary, the device will undergo 
modifications towards improvements in clinical procedures.
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